论文部分内容阅读
目的:探讨加味止嗽散治疗小儿咳嗽变异性哮喘的临床疗效。方法:选取咳嗽变异性哮喘患儿106例,随机分为观察组和对照组各53例,观察组患儿给予加味止嗽散治疗,对照组患儿给予布地奈德混悬液雾化吸入治疗。比较两组患儿临床疗效和半年复发情况。结果:经过治疗,观察组总有效率为96.23%,高于对照组的83.02%,差异有统计学意义(P<0.05);随访半年,观察组复发率为1.96%,对照组复发率为18.18%,观察组复发率明显低于对照组,差异有统计学意义(P<0.05)。结论:加味止嗽散治疗小儿咳嗽变异性哮喘疗效显著,不易复发,值得临床推广应用。
Objective: To investigate the clinical efficacy of Modified Zhisowan San in treating cough variant asthma in children. Methods: A total of 106 children with cough variant asthma were randomly divided into observation group (53 cases) and control group (53 cases). The observation group was given Jiawei Zhaoshao San (treatment group), while the control group was given budesonide suspension aerosol inhalation . The clinical efficacy and recurrence of six months in both groups were compared. Results: After treatment, the total effective rate of the observation group was 96.23%, which was higher than that of the control group (83.02%), the difference was statistically significant (P <0.05). The recurrence rate was 1.96% in the observation group and 18.18 in the control group %, The recurrence rate of the observation group was significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion: Modified Zhisowan San treatment of children with cough variant asthma significant effect, not easy to relapse, worthy of clinical application.